Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

MOPH Mobile Application

 

“Haak bi Idak… Wajebna nfidik”

Under the theme “Haak bi Idak… Wajebna nfidik”, the minister of Public Health Ali Hasan Khalil launched this afternoon the first mobile application within the national E-Health programme. This app aims at providing general services through the dissemination of information related to the services provided by the Ministry of Public Health and the way to access them with modern ICT and social media.

The Director of the national E-Health programme Mrs. Lina Abou Mrad introduced the goals and applications of the programme that grants every citizen the right to access the suitable information from the administration to get the required service. The application enables the citizen to keep informed on the prices of registered drugs and the conditions of benefiting from the drugs provided by the Ministry for chronic or incurable diseases … a guide for the governmental and private hospitals, the names of the inspection doctors working for them, the primary health care centers, the awareness campaigns of the ministry, the section of complaints, the links to the website, the sanitary materials uploaded to You Tube and all the activities of the ministry… in the best and fastest possible means. It activates as well the accountability through the adoption of a procedure to lodge complaints.

The head of Medical Professions Department Antoine Romanos then introduced projects to enhance and facilitate the procedures at the ministry through this application, most important of which: the improvement of the conduct of procedures and the related regulations, the adoption of transparency to improve the public service, a better understanding of the citizens’ needs, the simplification of procedures to end the unnecessary or expensive forms of regulation, the use of the ICT STOP SHOP, the review of the rules and regulations to keep up with the administrative development and the introduction of the ONE stop Shop for the administrative transactions…

Minister Khalil noted that the meeting is to renew the confidence that has always existed in the state and institutions and their ability to accomplish great achievements. This is one the achievements of the Ministry of Public health’s team, administrators and employees. However it was clear that when the idea of the introduction of this app was advanced for the service of the Lebanese citizen, a team of administrators was fully ready. Khalil commended the role of Mrs. Abou Mrad and her commitment to provide all the necessary data for the application.

Minister Khalil handed out certificates of recognition to those who contributed in the completion of the work.
 
To download the mobile app:
 
On
 Google Play or  App Store
OR  For more information:
 
    ...
    66
    ...
ATC Name B/G Ingredients Dosage Form Price
S01AE01 OFLOX B Ofloxacin - 0.3% 0.3% Drops solution 366,869 L.L
L04AA52 KESIMPTA BioTech Ofatumumab - 20mg/0.4ml 20mg/0.4ml Injectable solution 96,542,598 L.L
L04AA52 KESIMPTA BioTech Ofatumumab - 20mg/0.4ml 20mg/0.4ml Injectable solution L.L
H01CB02 SANDOSTATIN B Octreotide - 0.1mg/ml 0.1mg/ml Injectable solution 1,038,790 L.L
H01CB02 SANDOSTATIN LAR B Octreotide (acetate) - 30mg 30mg Injectable powder for suspension+diluent 57,182,544 L.L
H01CB02 SANDOSTATIN LAR B Octreotide (acetate) - 30mg 30mg Injectable powder for suspension+diluent L.L
H01CB02 SANDOSTATIN LAR B Octreotide (acetate) - 20mg 20mg Injectable powder for suspension+diluent 38,121,223 L.L
H01CB02 SANDOSTATIN LAR B Octreotide (acetate) - 20mg 20mg Injectable powder for suspension+diluent L.L
L04AA36 OCREVUS BioTech Ocrelizumab - 920mg/23ml 920mg/23ml Injectable solution 1,095,034,629 L.L
L04AA36 OCREVUS BioTech Ocrelizumab - 300mg/10ml 300mg/10ml Injectable concentrate for solution 547,517,314 L.L
L04AA36 OCREVUS BioTech Ocrelizumab - 300mg/10ml 300mg/10ml Injectable concentrate for solution L.L
L01FA03 GAZYVA BioTech Obinutuzumab - 1000mg/40ml 1000mg/40ml Injectable concentrate for solution 314,437,416 L.L
L01FA03 GAZYVA BioTech Obinutuzumab - 1000mg/40ml 1000mg/40ml Injectable concentrate for solution L.L
A05AA04 OCALIVA B Obeticholic acid - 5mg 5mg Tablet, film coated 224,503,943 L.L
A05AA04 OCALIVA B Obeticholic acid - 10mg 10mg Tablet, film coated 224,503,943 L.L
R05X TRIMEDIL FORTE G O-(?-hydroxyethyl)-rutosides - 30mg, Ascorbic acid - 80mg, Dimethindene - 0.5mg, Phenylephrine HCl - 2.5mg, Paracetamol - 200mg Capsule 386,515 L.L
A07AA02 MEDISTAN G Nystatin - 500,000IU/5ml 500,000IU/5ml Suspension 415,951 L.L
A07AA02 MEDISTAN G Nystatin - 500,000IU 500,000IU Capsule 417,231 L.L
A07AA02 MEDISTAN G Nystatin - 200.000IU 200.000IU Lozenge 418,511 L.L
G01AA51 TERGYNAN G Nystatin - 100000IU, Neomycin (sulfate) - 65000IU, Metronidazole - 500mg Tablet 348,055 L.L
G01AA51 POLYGYNAX B Nystatin - 100,000IU, Polymixin B sulfate - 35,000IU, Neomycin sulfate - 35,000IU Capsule, vaginal 407,184 L.L
G01AA51 GYNAMEND G Nystatin - 100,000IU, Neomycin (sulfate) - 35,000IU, Polymyxin B sulfate - 35,000IU Capsule, soft 345,560 L.L
R05FA02 TUSCALMAN A B Noscapine HCl - 5mg, Guaifenesin - 25mg Suppository 624,963 L.L
R05FA02 TUSCALMAN B B Noscapine HCl - 10mg, Guaifenesin - 50mg Suppository 615,992 L.L
G03FB01 PROGYLUTON B Norgestrel - 0.5mg (tablet 2), Estradiol valerate - 2mg (tablet 1, tablet 2) Tablet 193,513 L.L
J01MA06 NOROXIN B Norfloxacin - 400mg 400mg Tablet, film-scored 574,653 L.L
S01AE02 NAFLOX G Norfloxacin - 3mg/ml 3mg/ml Drops 370,901 L.L
G03DC02 PRIMOLUT NOR B Norethisterone acetate - 5mg 5mg Tablet 296,989 L.L
C01CA03 NORADRENALINE RENAUDIN G Norepinephrine tartrate - 8mg/4ml 0.2% Injectable solution 2,000,981 L.L
C01CA03 ? NORADRENALINE G Norepinephrine tartrate - 8mg/4ml 8mg/4ml Injectable solution 330,201 L.L
    ...
    66
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025